Cargando…

Implementing and Evaluating the Impact of BoneRx: A Healthy Bone Prescription for Men with Prostate Cancer Initiating Androgen Deprivation Therapy

Background: The initiation of Androgen Deprivation Therapy (ADT) results in rapid and profound hypogonadism, resulting in significant bone and muscle loss, increasing the risk for osteoporosis (OP), falls, and fractures. Despite this, there exist very low rates of guideline adherent care regarding b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Jennifer M., Tsang, Derek S., Zheng, Shiyu, Yeheskel, Ariel, Catton, Charles N., Cheung, Angela M., Hamilton, Robert, Alibhai, Shabbir M. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144215/ https://www.ncbi.nlm.nih.gov/pubmed/35628830 http://dx.doi.org/10.3390/jcm11102703

Ejemplares similares

Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer
por: Morrison, Belinda F, et al.
Publicado: (2011)

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy
por: Neubecker, Katherine, et al.
Publicado: (2011)

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
por: Neubecker, Katherine, et al.
Publicado: (2017)

A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
por: Alibhai, Shabbir M. H., et al.
Publicado: (2019)

A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
por: Alibhai, Shabbir MH, et al.
Publicado: (2015)

Androgen Deprivation Therapy Differentially Impacts Bone and Muscle in the Short Term in Physically Active Men With Prostate Cancer
por: Maalouf, Naim M., et al.
Publicado: (2021)

Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition
por: Taaffe, Dennis R., et al.
Publicado: (2018)

Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review
por: Bressi, Barbara, et al.
Publicado: (2020)

Androgen Deprivation Alters Attention to Sexually Provocative Visual Stimuli in Elderly Men
por: Palmer-Hague, Jaime L., et al.
Publicado: (2017)

Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update
por: Owen, P J, et al.
Publicado: (2017)

Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
por: Varenhorst, Eberhard, et al.
Publicado: (2016)

Effect of androgen deprivation therapy on bone mineral density in patients with prostate cancer
por: Ilyas, Kashaf, et al.
Publicado: (2022)

Androgen deprivation and SARS-CoV-2 in men with prostate cancer
por: Koskinen, M., et al.
Publicado: (2020)

RiseTx: testing the feasibility of a web application for reducing sedentary behavior among prostate cancer survivors receiving androgen deprivation therapy
por: Trinh, Linda, et al.
Publicado: (2018)

Correction to: RiseTx: testing the feasibility of a web application for reducing sedentary behavior among prostate cancer survivors receiving androgen deprivation therapy
por: Trinh, Linda, et al.
Publicado: (2018)

Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review
por: Cagliari, Maribel, et al.
Publicado: (2021)

Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy
por: Reza, Mariana, et al.
Publicado: (2014)

Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer
por: Hussain, Arif, et al.
Publicado: (2020)

Hypothalamic-Pituitary-Thyroid Axis Set Point Alterations Are Associated With Body Composition in Androgen-Deprived Men
por: Hoermann, Rudolf, et al.
Publicado: (2017)

Bone densitometric assessment and management of fracture risk in Indian men of prostate cancer on androgen deprivation therapy: Does practice pattern match the guidelines?
por: Pradhan, Manas R., et al.
Publicado: (2012)

Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapy
por: Pan, Belinda, et al.
Publicado: (2022)

Effects of a lifestyle intervention on endothelial function in men on long-term androgen deprivation therapy for prostate cancer
por: Gilbert, Stephen E, et al.
Publicado: (2016)

Androgen Deprivation Therapy Toxicity and Management for Men Receiving Radiation Therapy
por: Johnson, Matthew E., et al.
Publicado: (2012)

How do we define “castration” in men on androgen deprivation therapy?
por: Itty, Sarin, et al.
Publicado: (2020)

Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer
por: Gagliano-Jucá, Thiago, et al.
Publicado: (2018)

Bone Mass and the CAG and GGN Androgen Receptor Polymorphisms in Young Men
por: Guadalupe-Grau, Amelia, et al.
Publicado: (2010)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Androgen Deprivation Therapy, Hypogonadism and Cardiovascular Toxicity in Men with Advanced Prostate Cancer
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2021)

Association between Androgen Deprivation Therapy and Risk of Dementia in Men with Prostate Cancer
por: Liu, Jui-Ming, et al.
Publicado: (2021)

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
por: Shah, Neil J, et al.
Publicado: (2022)

Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment
por: Bock, Nathalie, et al.
Publicado: (2019)

SUN-536 Assessment of Bone Health Status in Veterans Requiring Androgen-Deprivation Therapy for Prostate Cancer
por: Oprea, Mihaela, et al.
Publicado: (2019)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Pathophysiology of Bone Loss in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy and Lifestyle Modifications for the Management of Bone Health: A Comprehensive Review
por: Kim, Tae Jin, et al.
Publicado: (2020)

Impact of CancelRx on discontinuation of controlled substance prescriptions: an interrupted time series analysis
por: Watterson, Taylor L., et al.
Publicado: (2022)

Social prescription in the US: A pilot evaluation of Mass Cultural Council's “CultureRx”
por: Golden, Tasha L., et al.
Publicado: (2023)

Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review
por: Andela, Cornelie D, et al.
Publicado: (2021)

Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer
por: Cherrier, M. M., et al.
Publicado: (2018)

Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer
por: Suarez-Almazor, Maria E., et al.
Publicado: (2022)

Survival following primary androgen deprivation therapy among men with localized prostate cancer
por: Vasudeva, Pawan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_dqop2ang9j1fmrh792gsdtvvjo